0000950170-24-016357.txt : 20240216 0000950170-24-016357.hdr.sgml : 20240216 20240216161007 ACCESSION NUMBER: 0000950170-24-016357 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200401 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EW HEALTHCARE PARTNERS FUND 2-A, L.P. CENTRAL INDEX KEY: 0001746779 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39130 FILM NUMBER: 24648419 BUSINESS ADDRESS: STREET 1: 280 PARK AVENUE, 27TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (646) 429-1251 MAIL ADDRESS: STREET 1: 280 PARK AVENUE, 27TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EW HEALTHCARE PARTNERS FUND 2, L.P. CENTRAL INDEX KEY: 0001746777 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39130 FILM NUMBER: 24648420 BUSINESS ADDRESS: STREET 1: 280 PARK AVENUE, 27TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (646) 429-1251 MAIL ADDRESS: STREET 1: 280 PARK AVENUE, 27TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EW Healthcare Partners Fund 2-UGP, LLC CENTRAL INDEX KEY: 0001793948 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39130 FILM NUMBER: 24648417 BUSINESS ADDRESS: STREET 1: 21 WATERWAY AVENUE STREET 2: SUITE 225 CITY: THE WOODLANDS STATE: TX ZIP: 77380 BUSINESS PHONE: 2813641555 MAIL ADDRESS: STREET 1: 21 WATERWAY AVENUE STREET 2: SUITE 225 CITY: THE WOODLANDS STATE: TX ZIP: 77380 FORMER NAME: FORMER CONFORMED NAME: EW Healthcare Partners Fund 2-UGP, L.P. DATE OF NAME CHANGE: 20191113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EW Healthcare Partners Fund 2 GP, L.P. CENTRAL INDEX KEY: 0001793943 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39130 FILM NUMBER: 24648418 BUSINESS ADDRESS: STREET 1: 21 WATERWAY AVENUE STREET 2: SUITE 225 CITY: THE WOODLANDS STATE: TX ZIP: 77380 BUSINESS PHONE: 2813641555 MAIL ADDRESS: STREET 1: 21 WATERWAY AVENUE STREET 2: SUITE 225 CITY: THE WOODLANDS STATE: TX ZIP: 77380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TELA Bio, Inc. CENTRAL INDEX KEY: 0001561921 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 455320061 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-320-2930 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24 CITY: MALVERN STATE: PA ZIP: 19355 4 1 ownership.xml 4 X0508 4 2020-04-01 false 0001561921 TELA Bio, Inc. TELA 0001746777 EW HEALTHCARE PARTNERS FUND 2, L.P. 21 WATERWAY AVENUE, SUITE 225 THE WOODLANDS TX 77380 false false true true See Remarks 0001746779 EW HEALTHCARE PARTNERS FUND 2-A, L.P. 21 WATERWAY AVENUE, SUITE 225 THE WOODLANDS TX 77380 false false true true See Remarks 0001793943 EW Healthcare Partners Fund 2 GP, L.P. 21 WATERWAY AVENUE, SUITE 225 THE WOODLANDS TX 77380 false false true true See Remarks 0001793948 EW Healthcare Partners Fund 2-UGP, LLC 21 WATERWAY AVENUE, SUITE 225 THE WOODLANDS TX 77380 false false true true See Remarks false Common Stock, par value $0.001 per share 2020-04-01 4 P false 15000 7.47 A 1169231 I See Remarks Common Stock, par value $0.001 per share 2020-04-02 4 P false 15000 8.01 A 1184231 I See Remarks Common Stock, par value $0.001 per share 2020-04-03 4 P false 9634 8.01 A 1193865 I See Remarks Common Stock, par value $0.001 per share 2020-04-06 4 P false 17866 8.10 A 1211731 I See Remarks Common Stock, par value $0.001 per share 2020-04-07 4 P false 20000 8.20 A 1231731 I See Remarks Common Stock, par value $0.001 per share 2020-04-08 4 P false 15000 8.37 A 1246731 I See Remarks Common Stock, par value $0.001 per share 2020-04-09 4 P false 25000 8.47 A 1271731 I See Remarks Common Stock, par value $0.001 per share 2020-04-13 4 P false 10000 7.96 A 1281731 I See Remarks Common Stock, par value $0.001 per share 2020-04-14 4 P false 15000 8.07 A 1296731 I See Remarks Common Stock, par value $0.001 per share 2020-04-15 4 P false 12500 7.99 A 1309231 I See Remarks Common Stock, par value $0.001 per share 2020-04-16 4 P false 17500 8.00 A 1326731 I See Remarks Common Stock, par value $0.001 per share 2020-04-17 4 P false 25000 8.25 A 1351731 I See Remarks Common Stock, par value $0.001 per share 2020-04-20 4 P false 7000 8.06 A 1358731 I See Remarks Common Stock, par value $0.001 per share 2020-04-21 4 P false 3037 8.32 A 1361768 I See Remarks Common Stock, par value $0.001 per share 2020-04-22 4 P false 10000 9.14 A 1371768 I See Remarks Common Stock, par value $0.001 per share 2020-04-23 4 P false 15000 9.98 A 1386768 I See Remarks Common Stock, par value $0.001 per share 2020-04-28 4 P false 5000 9.48 A 1391768 I See Remarks Common Stock, par value $0.001 per share 2020-07-28 4 P false 10000 12.48 A 1401768 I See Remarks Common Stock, par value $0.001 per share 2020-07-29 4 P false 12600 12.39 A 1414368 I See Remarks Common Stock, par value $0.001 per share 2020-07-30 4 P false 7400 12.22 A 1421768 I See Remarks Common Stock, par value $0.001 per share 2020-07-31 4 P false 31825 11.86 A 1453593 I See Remarks Common Stock, par value $0.001 per share 2020-08-03 4 P false 1400 11.86 A 1454993 I See Remarks Common Stock, par value $0.001 per share 2020-08-04 4 P false 10200 12.72 A 1465193 I See Remarks Common Stock, par value $0.001 per share 2020-08-11 4 P false 821 12.95 A 1466014 I See Remarks Common Stock, par value $0.001 per share 2020-08-14 4 P false 9179 12.95 A 1475193 I See Remarks Common Stock, par value $0.001 per share 2020-08-28 4 P false 100 12.85 A 1475293 I See Remarks Common Stock, par value $0.001 per share 2022-07-14 4 P false 5000 8.01 A 3610709 I See Remarks The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.56 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("EW Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A," and together with EW Fund 2, the "EW Funds"), on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,917 shares of the amount shown above and EW Fund 2-A purchased 5,717 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.16 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 7,265 shares of the amount shown above and EW Fund 2-A purchased 10,601 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.98 to $8.39 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 8,133 shares of the amount shown above and EW Fund 2-A purchased 11,867 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.36 to $8.38 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.35 to $8.58 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 10,166 shares of the amount shown above and EW Fund 2-A purchased 14,834 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.93 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.09 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.97 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 5,083 shares of the amount shown above and EW Fund 2-A purchased 7,417 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.99 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 7,116 shares of the amount shown above and EW Fund 2-A purchased 10,384 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.18 to $8.29 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 10,166 shares of the amount shown above and EW Fund 2-A purchased 14,834 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.03 to $8.14 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 2,846 shares of the amount shown above and EW Fund 2-A purchased 4,154 shares of the amount shown above. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 1,235 shares of the amount shown above and EW Fund 2-A purchased 1,802 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.08 to $9.19 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $9.99 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 2,033 shares of the amount shown above and EW Fund 2-A purchased 2,967 shares of the amount shown above. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.34 to $12.40 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 5,124 shares of the amount shown above and EW Fund 2-A purchased 7,476 shares of the amount shown above. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,009 shares of the amount shown above and EW Fund 2-A purchased 4,391 shares of the amount shown above. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $12.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 12,941 shares of the amount shown above and EW Fund 2-A purchased 18,884 shares of the amount shown above. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 569 shares of the amount shown above and EW Fund 2-A purchased 831 shares of the amount shown above. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,148 shares of the amount shown above and EW Fund 2-A purchased 6,052 shares of the amount shown above. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 334 shares of the amount shown above and EW Fund 2-A purchased 487 shares of the amount shown above. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,732 shares of the amount shown above and EW Fund 2-A purchased 5,447 shares of the amount shown above. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 41 shares of the amount shown above and EW Fund 2-A purchased 59 shares of the amount shown above. The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 1,965 shares of the amount shown above and EW Fund 2-A purchased 3,035 shares of the amount shown above. The amounts reported in Column 5 of Table I reflect the aggregate number of shares of common stock held by the reporting persons as of the date of each respective transaction. As of the date of this filing, the reporting persons owned an aggregate 4,110,709 shares (the "Shares"), 1,615,368 of which are held by EW Fund 2 and 2,495,341 of which are held by EW Fund 2-A. EW Healthcare Partners Fund 2-GP, L.P. ("EW Funds GP"), is the general partner of each of the EW Funds. EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the Shares. The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the '"Managers"') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein. EW HEALTHCARE PARTNERS FUND 2, L.P., By: EW Healthcare Partners Fund 2-GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter 2024-02-16 EW HEALTHCARE PARTNERS FUND 2-A, L.P., By: EW Healthcare Partners Fund 2-GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter 2024-02-16 EW HEALTHCARE PARTNERS FUND 2-GP, L.P., By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter 2024-02-16 EW HEALTHCARE PARTNERS FUND 2-UGP, LLC, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter 2024-02-16